Cargando…
Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma
Due to fewer adverse events, faster onset of action, and longer durable responses compared to chemotherapy, immunotherapy has been widely used to treat advanced solid tumors. Moreover, immunotherapy can improve the autoimmune status, thus allowing patients to benefit from the treatment in the long t...
Autores principales: | Jin, Bo, Han, Wencong, Guo, Jingjing, Tian, Jie, He, Shiming, Gong, Yanqing, Zhou, Jingcheng, He, Qun, Shen, Qi, Zhang, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768187/ https://www.ncbi.nlm.nih.gov/pubmed/36568391 http://dx.doi.org/10.3389/fgene.2022.1022131 |
Ejemplares similares
-
Tumour microenvironment in pheochromocytoma and paraganglioma
por: Martinelli, Serena, et al.
Publicado: (2023) -
International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
por: Ben Aim, Laurene, et al.
Publicado: (2022) -
Novel and recurrent genetic variants of VHL, SDHB, and RET genes in Chinese pheochromocytoma and paraganglioma patients
por: Li, Chong, et al.
Publicado: (2023) -
Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020) -
SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas
por: Manotas, María Carolina, et al.
Publicado: (2023)